Literature DB >> 3702863

The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes.

P M Lippiello, K G Fernandes.   

Abstract

The binding of optically pure L-[3H]nicotine to rat brain membrane preparations was studied using a rapid filtration method. The binding properties observed depended on the method used for tissue isolation. The most consistent results were obtained with membranes prepared in the presence of protease inhibitors, without divalent cations. Binding was saturable, reversible, and stereospecific. Scatchard analysis revealed a single class of high affinity sites with an average KD of 2 nM and a Bmax of approximately 200 fmol/mg of protein. The Hill coefficient was near unity. The KD calculated from the kinetic rate constants for association (k1 = 0.012 min-1 nM-1) and dissociation (k-1 = 0.04 min-1) was around 3 nM, in good agreement with the dissociation constant determined from equilibrium binding. In competition studies, cholinergic agonists were generally the most effective in inhibiting L-[3H]nicotine binding, whereas antagonists were relatively ineffective. The D-isomer of nicotine was about 60-fold less potent than the L-isomer in inhibiting binding. The results were unaffected by temperature, with the exception that Bmax was somewhat lower at 37 degrees. The equilibrium binding properties of these sites were essentially identical in adult male and female brain. However, Bmax was lower in fetal brain tissue. The present findings are consistent with the idea that there is a single class of high affinity nicotinic binding sites in rat brain with cholinoceptive properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702863

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

1.  Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularis.

Authors:  I Miyai; S Ueno; S Yorifuji; H Fujimura; S Tarui
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 2.  Nicotine and nonnicotine factors in cigarette addiction.

Authors:  Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

Review 3.  Molecular studies of the neuronal nicotinic acetylcholine receptor family.

Authors:  J Lindstrom; R Schoepfer; P Whiting
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

4.  Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.

Authors:  David C Kombo; Anatoly Mazurov; Kartik Tallapragada; Philip S Hammond; Joseph Chewning; Terry A Hauser; Montserrat Vasquez-Valdivieso; Daniel Yohannes; Todd T Talley; Palmer Taylor; William S Caldwell
Journal:  Eur J Med Chem       Date:  2011-09-29       Impact factor: 6.514

5.  Radioiodination of nicotine with specific activity high enough for mapping nicotinic acetylcholine receptors.

Authors:  I Kämpfer; D Sorger; R Schliebs; W Kärger; K Günther; K Schulze; W H Knapp
Journal:  Eur J Nucl Med       Date:  1996-02

6.  Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.

Authors:  Imju Jeong; Bok Hee Choi; Sang June Hahn
Journal:  Pflugers Arch       Date:  2010-08-24       Impact factor: 3.657

7.  Differential effect of nicotinic agonists on the [3H]norepinephrine release from rat hippocampal slices.

Authors:  J P Kiss; K Windisch; K De Oliveira; E C Hennings; A Mike; B K Szász
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 8.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

9.  α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.

Authors:  Maryka Quik; Carla Campos; Tanuja Bordia; Jon-Paul Strachan; Jenny Zhang; J Michael McIntosh; Sharon Letchworth; Kristen Jordan
Journal:  Neuropharmacology       Date:  2013-04-12       Impact factor: 5.250

10.  Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats.

Authors:  Samuel A Roiko; Andrew C Harris; Mark G LeSage; Daniel E Keyler; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2009-04-23       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.